Neurosurgical procedure
ProcedureAny neurosurgical procedure in the National Neurosurgical Audit Programme (NNAP) Coding Framework of neurosurgical procedures.
NCT Number: NCT05097066
Neurosurgical practice has seen many important changes over several decades with advances in treatments and the types of patients treated. Neurosurgical procedures have evolved, and as outcomes have improved the number of patients being treated has increased.
There are no recent evaluations of national neurosurgical practice in the United Kingdom (UK), with the last prospective cohort studies being Safe Neurosurgery 1993 and Safe Neurosurgery 2000. More recent studies of neurosurgical services have been based on data from single institutions or surgeons and these may not give a representative picture of practice nationally.
Recent national quality improvement programmes for neurosurgery in England (such as the National Neurosurgical Audit Programme (NNAP) and Cranial Neurosurgery and Spinal Surgery Getting It Right First Time (GIRFT) Programmes) have focused on using national hospital administrative datasets. To be effective, quality improvement initiatives require robust outcome measures and quality (process) indicators. Currently, there is a lack of validated quality indicators for neurosurgery, with practice often being described using generic measures such as readmission and reoperation rates and length of stay. Many studies have been able to derive these common outcome measures, but it may also be possible to produce indicators specific to neurosurgery.
The aim of this observational study was firstly to describe the current pattern of neurosurgical admissions and procedures in England, and thereby given an overview of the epidemiology of neurosurgical patients. Secondly, it aims to investigate the range of outcome measures that might be produced from hospital administrative data and use these to assess the quality of care in neurosurgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Any neurosurgical procedure in the National Neurosurgical Audit Programme (NNAP) Coding Framework of neurosurgical procedures.
Time frame: From date of admission to date of discharge from hospital; assessed up to 60 months.
Length of the hospital admission to neurosurgery
Time frame: From date of admission to date of discharge from hospital; assessed up to 60 months.
A further neurosurgical procedure in admissions where patients have had a primary (main) neurosurgical procedure.
Time frame: Determined on date of discharge from hospital; assessed up to 60 months.
Proportion of patients discharged to their normal address.
Time frame: From date of the neurosurgical procedure through date of death from any cause (in-patient deaths only); assessed up to 60 months.
In-patient mortality after a neurosurgical procedure.
University of Leeds
Other
Patterns and Outcomes of Neurosurgery in England Over a Five-year Period: a National Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03981835
Cardiac Surgery, Percutaneous Coronary Intervention
Jacksonville, Florida, United States
View Trial DetailsNCT02284126
Bacterial Infections, Bacterial Infections and Mycoses
New York, United States
View Trial DetailsNCT04410419
Diabetes Mellitus, Diabetes Mellitus, Type 2
Edmonton, Alberta, Canada
View Trial DetailsNCT04732689
Digestive System Diseases, Hepatic Insufficiency
Montreal, Quebec, Canada
View Trial Details